News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,284 Results
Type
Article (45287)
Company Profile (336)
Press Release (705649)
Multimedia
Podcasts (114)
Webinars (19)
Section
Business (212405)
Career Advice (2113)
Deals (36523)
Drug Delivery (118)
Drug Development (82655)
Employer Resources (177)
FDA (16979)
Job Trends (15411)
News (357431)
Policy (33615)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2722)
Accelerated approval (33)
Adcomms (24)
Allergies (146)
Alliances (52620)
ALS (172)
Alzheimer's disease (1696)
Antibody-drug conjugate (ADC) (327)
Approvals (17244)
Artificial intelligence (564)
Autoimmune disease (162)
Automation (42)
Bankruptcy (366)
Best Places to Work (11930)
BIOSECURE Act (20)
Biosimilars (193)
Biotechnology (222)
Bladder cancer (159)
Brain cancer (58)
Breast cancer (648)
Cancer (4903)
Cardiovascular disease (405)
Career advice (1789)
Career pathing (37)
CAR-T (295)
CDC (45)
Celiac Disease (2)
Cell therapy (778)
Cervical cancer (36)
Clinical research (70431)
Collaboration (1791)
Company closure (4)
Compensation (1179)
Complete response letters (57)
COVID-19 (2799)
CRISPR (100)
C-suite (886)
Cystic fibrosis (149)
Data (6318)
Decentralized trials (2)
Denatured (43)
Depression (137)
Diabetes (507)
Diagnostics (6976)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (269)
Drug pricing (187)
Drug shortages (30)
Duchenne muscular dystrophy (237)
Earnings (91918)
Editorial (58)
Employer branding (22)
Employer resources (157)
Events (122219)
Executive appointments (1015)
FDA (20172)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1531)
Gene editing (213)
Generative AI (50)
Gene therapy (628)
GLP-1 (987)
Government (4767)
Grass and pollen (7)
Guidances (386)
Healthcare (19602)
HIV (64)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (256)
Immuno-oncology (58)
Indications (115)
Infectious disease (3079)
Inflammatory bowel disease (197)
Inflation Reduction Act (14)
Influenza (121)
Intellectual property (260)
Interviews (327)
IPO (16990)
IRA (51)
Job creations (3831)
Job search strategy (1500)
JPM (61)
Kidney cancer (16)
Labor market (87)
Layoffs (563)
Leadership (33)
Legal (8172)
Liver cancer (93)
Longevity (14)
Lung cancer (655)
Lymphoma (382)
Machine learning (44)
Management (63)
Manufacturing (822)
MASH (165)
Medical device (14523)
Medtech (14579)
Mergers & acquisitions (20622)
Metabolic disorders (1286)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (322)
Neuropsychiatric disorders (88)
Neuroscience (2951)
Neurotech (1)
NextGen: Class of 2026 (6852)
Non-profit (4653)
Now hiring (67)
Obesity (602)
Opinion (275)
Ovarian cancer (167)
Pain (200)
Pancreatic cancer (232)
Parkinson's disease (284)
Partnered (34)
Patents (514)
Patient recruitment (503)
Peanut (59)
People (61185)
Pharmaceutical (70)
Pharmacy benefit managers (29)
Phase 1 (22114)
Phase 2 (30968)
Phase 3 (22983)
Pipeline (5415)
Policy (292)
Postmarket research (2583)
Preclinical (9464)
Press Release (71)
Prostate cancer (242)
Psychedelics (48)
Radiopharmaceuticals (302)
Rare diseases (854)
Real estate (6284)
Recruiting (70)
Regulatory (25154)
Reports (53)
Research institute (2530)
Resumes & cover letters (364)
Rett syndrome (27)
RNA editing (19)
RSV (79)
Schizophrenia (151)
Series A (252)
Series B (194)
Service/supplier (14)
Sickle cell disease (99)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (43)
Startups (3881)
State (2)
Stomach cancer (17)
Supply chain (106)
Tariffs (84)
The Weekly (69)
Vaccines (1051)
Venture capital (94)
Weight loss (387)
Women's health (93)
Worklife (18)
Date
Today (182)
Last 7 days (594)
Last 30 days (2270)
Last 365 days (30673)
2026 (3745)
2025 (30958)
2024 (36216)
2023 (41137)
2022 (52399)
2021 (56995)
2020 (55613)
2019 (48407)
2018 (36441)
2017 (33541)
2016 (33142)
2015 (39360)
2014 (32942)
2013 (27986)
2012 (30243)
2011 (30848)
2010 (28810)
Location
Africa (777)
Alabama (86)
Alaska (7)
Arizona (319)
Arkansas (14)
Asia (41957)
Australia (6970)
California (11551)
Canada (3322)
China (1132)
Colorado (490)
Connecticut (494)
Delaware (351)
Europe (92118)
Florida (1709)
Georgia (370)
Hawaii (3)
Idaho (64)
Illinois (894)
India (68)
Indiana (534)
Iowa (23)
Japan (442)
Kansas (131)
Kentucky (41)
Louisiana (27)
Maine (72)
Maryland (1403)
Massachusetts (8348)
Michigan (352)
Minnesota (648)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (28)
Nevada (125)
New Hampshire (85)
New Jersey (3062)
New Mexico (30)
New York (3034)
North Carolina (1510)
North Dakota (10)
Northern California (5618)
Ohio (344)
Oklahoma (22)
Oregon (44)
Pennsylvania (2315)
Puerto Rico (25)
Rhode Island (49)
South America (1166)
South Carolina (67)
South Dakota (1)
Southern California (4502)
Tennessee (179)
Texas (1791)
United States (41097)
Utah (346)
Vermont (1)
Virginia (270)
Washington D.C. (82)
Washington State (948)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
751,284 Results for "vitreoretinal technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Primary Large B-Cell Lymphomas of Immune-Privileged Sites, including Primary Vitreoretinal Lymphoma
August 29, 2025
·
8 min read
Press Releases
DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.
February 3, 2026
·
2 min read
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.
January 15, 2026
·
5 min read
Press Releases
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 16, 2026
·
3 min read
Press Releases
Medical Care Technologies Inc. (OTC Pink:MDCE) Announces Attendance at CES 2026 in Las Vegas
January 7, 2026
·
2 min read
Press Releases
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution
January 8, 2026
·
6 min read
Press Releases
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
December 17, 2025
·
3 min read
Press Releases
Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma
June 26, 2025
·
8 min read
Press Releases
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
December 30, 2025
·
4 min read
Business
Vitreoretinal Surgeon and Key Thought Leader Roger Goldberg, M.D., Joins Kiora Pharmaceuticals’ Scientific Advisory Board
Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed Roger A. Goldberg, MD, MBA, a vitreoretinal surgeon at Bay Area Retina Associates (BARA) to its Scientific Advisory Board. As an advisor, Dr. Goldberg will contribute scientific insights and valued clinical perspectives to aid Kiora’s development of new therapeutics to address retinal diseases with high unmet needs.
June 25, 2024
·
5 min read
1 of 75,129
Next
